Pulse Biosciences (PLSE) Change in Cash (2020 - 2025)
Pulse Biosciences has reported Change in Cash over the past 6 years, most recently at -$14.5 million for Q4 2025.
- Quarterly results put Change in Cash at -$14.5 million for Q4 2025, down 137.12% from a year ago — trailing twelve months through Dec 2025 was -$37.3 million (down 150.63% YoY), and the annual figure for FY2025 was -$37.3 million, down 150.63%.
- Change in Cash for Q4 2025 was -$14.5 million at Pulse Biosciences, down from -$11.1 million in the prior quarter.
- Over the last five years, Change in Cash for PLSE hit a ceiling of $54.4 million in Q3 2022 and a floor of -$15.9 million in Q1 2022.
- Median Change in Cash over the past 5 years was -$7.5 million (2022), compared with a mean of $3.4 million.
- Peak annual rise in Change in Cash hit 4813.99% in 2021, while the deepest fall reached 348.04% in 2021.
- Pulse Biosciences' Change in Cash stood at -$13.4 million in 2021, then soared by 40.02% to -$8.0 million in 2022, then rose by 24.95% to -$6.0 million in 2023, then surged by 747.82% to $39.0 million in 2024, then crashed by 137.12% to -$14.5 million in 2025.
- The last three reported values for Change in Cash were -$14.5 million (Q4 2025), -$11.1 million (Q3 2025), and -$12.9 million (Q2 2025) per Business Quant data.